Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10612816 | 0.92 | PPARD (0.44) | PPARDTSHR | |
| SCHEMBL2232173 | 0.88 | PPARD (0.50) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL7594334 | 0.84 | PPARD (0.47) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL9506230 | 0.84 | FAAH (0.31) | — | |
| SCHEMBL16638748 | 0.83 | PPARD (0.43) | PPARDTSHRTDP1CA12CA1 | |
| SCHEMBL4262691 | 0.82 | PPARD (0.45) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL28933751 | 0.79 | — | — | |
| SCHEMBL28926765 | 0.78 | PPARD (0.46) | PPARDTSHRCA12CA1CA2 | |
| SCHEMBL7268189 | 0.78 | PPARD (0.64) | PPARDTSHRTP53TDP1 | |
| SCHEMBL5017294 | 0.78 | PPARD (0.64) | PPARDTSHRTP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011441-A | Long glass fiber reinforced polyurethane composite material and preparation process and application thereof | 万仑新材料(上海)有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20230272014-A1 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG (DE) | 2023-08-31 | — | — | US | disclosed |
| US-20230181727-A1 | COMPOSITION OF NANOPARTICLES | LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG (DE) | 2023-06-15 | — | — | US | disclosed |
| US-7728159-B2 | Organopolysiloxanes containing phosphonic groups, method for the production and use thereof | PHOSPHONICS LIMITED (GB) | 2010-06-01 | — | — | US | disclosed |
| WO-2007006569-A1 | SUBSTITUTED ORGANOPOLYSILOXANES CONTAINING PHOSPHONIC GROUPS, METHODS FOR THE PRODUCTION AND USE THEREOF | PHOSPHONICS LTD (GB) | 2007-01-18 | — | — | WO | disclosed |
| US-20060241314-A1 | Organopolysiloxanes containing phosphonic groups, method for the production and use thereof | PHOSPHONICS LIMITED (GB) | 2006-10-26 | — | — | US | disclosed |
| EP-1360222-B1 | ORGANOPOLYSILOXANES CONTAINING PHOSPHONIC GROUPS, METHODS FOR THE PRODUCTION AND USE THEREOF | PHOSPHONICS LTD (GB) | 2006-09-06 | — | — | EP | disclosed |
| US-7064226-B2 | Organopolysiloxanes containing phosphonic groups, method for the production and use thereof | PHOSPHONICS LIMITED (GB) | 2006-06-20 | — | — | US | disclosed |
| US-20040077889-A1 | Organopolysiloxanes containing phosphonic groups, method for the production and use thereof | QUEEN MARY & WESTFIELD COLLEGE (GB) | 2004-04-22 | — | — | US | disclosed |
| EP-1360222-A1 | ORGANOPOLYSILOXANES CONTAINING PHOSPHONIC GROUPS, METHODS FOR THE PRODUCTION AND USE THEREOF | QUEEN MARY & WESTFIELD COLLEGE (GB) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002055587-A1 | ORGANOPOLYSILOXANES CONTAINING PHOSPHONIC GROUPS, METHODS FOR THE PRODUCTION AND USE THEREOF | QUEEN MARY & WESTFIELD COLLEGE (GB) | 2002-07-18 | — | — | WO | disclosed |
| US-5073475-A | PRODUCTION OF PLATE-LIKE, SHEET-LIKE OR TAPE-LIKE MATERIALS AND OF SENSITIZED LITHOGRAPHIC PRINTING PLATES | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-17 | — | — | US | disclosed |
| EP-0418575-A2 | Process for the manufacture of plates, foils, or sheet-like materials and process for the manufacture of presensitized lithographic printing plates | BASF Aktiengesellschaft (DE) | 1991-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241314-A1 | Organopolysiloxanes containing phosphonic groups, method for the production and use thereof | ORC3, ROR1, TYK2 | PPARD 2829/4885TSHR 2393/4885TP53 2893/4885 |
| US-20230181727-A1 | COMPOSITION OF NANOPARTICLES | CD47, CD63, HLA-C | PPARD 4296/4885TSHR 4502/4885TP53 6/4885 |
| US-20230272014-A1 | COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS | TP53, TSG101, CD47 | PPARD 4354/4885TSHR 4690/4885TP53 1/4885 |
| US-20040077889-A1 | Organopolysiloxanes containing phosphonic groups, method for the production and use thereof | RPS4Y1, ILK, RPS4X | PPARD 4714/4885TSHR 2269/4885TP53 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.